(153 days)
Not Found
No
The summary describes a mechanical balloon catheter for temporary vascular occlusion and delivery of agents. There is no mention of AI, ML, image processing, or any computational analysis of data.
Yes
The device is intended to selectively stop or control blood flow, deliver diagnostic agents, and deliver therapeutic agents, all of which are considered therapeutic uses.
No
The "Intended Use" section states that the device is intended for temporary occlusion of blood vessels and to assist in the delivery of diagnostic and therapeutic agents, not for diagnosing conditions.
No
The device description clearly describes a physical catheter with a balloon, lumens, and radiopaque markers, indicating it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes a device used within the body (in the blood vessels) for temporary occlusion and delivery of agents. This is an in vivo application.
- Device Description: The description details a physical catheter with a balloon designed for insertion into blood vessels. This is a medical device used for intervention, not for testing samples outside the body.
- Lack of IVD Characteristics: There is no mention of analyzing samples (blood, tissue, etc.) or providing diagnostic information based on such analysis. IVDs are typically used to diagnose diseases or conditions by examining samples in vitro (outside the body).
Therefore, the Micrus Ascent Occlusion Balloon Catheter is a medical device used for therapeutic and diagnostic delivery purposes within the body, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Micrus Ascent Occlusion Balloon Catheter is intended for use in the blood vessels of the peripheral and neuro vasculature where temporary occlusion is desired and offers a vessel selective technique of temporary vascular occlusion which is useful in selectively stopping or controlling blood flow. The Micrus Ascent Occlusion Balloon Catheter is also intended to assist in the delivery of diagnostic agents such as contrast media, and therapeutic agents such as occlusion coils, into the peripheral and neuro vasculature.
Product codes
MJN
Device Description
The Micrus® Ascent™ Occlusion Balloon Catheter is a coaxial dual lumen balloon catheter comprised of an inner guidewire lumen and a separate outer lumen to inflate and deflate the balloon. The balloon catheter is designed for use over any .014" or smaller guidewire. The balloon can be inflated and deflated independently of guidewire position. The balloon is equipped with a vent hole for easy preparation and removal of air from the balloon, and with two radiopaque markers for balloon positioning.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
blood vessels of the peripheral and neuro vasculature
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K984214, K993292, K011656, K060116
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc)
Not Found
§ 870.4450 Vascular clamp.
(a)
Identification. A vascular clamp is a surgical instrument used to occlude a blood vessel temporarily.(b)
Classification. Class II (performance standards).
0
Micrus Ascent Occlusion Balloon Catheter 510(k) Premarket Notification
AUG 2 7 2008
1/2
510(k) Summary 5.0
Micrus Endovascular Corporation Micrus® Ascent™ Occlusion Balloon Catheter
This 510(k) Summary for the Micrus® Ascent™ Occlusion Balloon Catheter is submitted in accordance with the requirements of 21 C.F.R. § 807.92.
GENERAL INFORMATION
| Manufacturer: | Micrus Endovascular Corporation
821 Fox Lane
San Jose, CA 95131
Phone: 408-433-1400,
Est. Registration No. 2954740 |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Patrick Lee
Phone: (408) 433-1428
Fax: (408) 433-1585
plee@micruscorp.com |
| Date Prepared: | March 25, 2008 |
DEVICE CLASSIFICATION
| Classification: | Class II |
|---|---|
| Trade Name: | Micrus® Ascent™ Occlusion Balloon Catheter |
| Generic/Common Name: | catheter, intravascular occluding, temporary (21CFR § 870.4450) |
PREDICATE DEVICES
- 510(k) no. K984214, Cordis Temporary Occlusion Balloon Catheter, Aug 10, 1999 .
- 510(k) no. K993292, Sentry Occlusion Balloon Catheter, May 23, 2000 .
- 510(k) no. K011656, MTI Hyperform Occlusion Balloon Catheter, Jun 20, 2001 .
- 510(k) no. K060116, Courier Straight Microcatheter, May 12, 2006 .
INTENDED USE
The Micrus Ascent Occlusion Balloon Catheter is intended for use in the blood vessels of the peripheral and neuro vasculature where temporary occlusion is desired and offers a vessel selective technique of temporary vascular occlusion which is useful in selectively stopping or controlling blood flow. The Micrus Ascent Occlusion Balloon Catheter is also intended to assist in the delivery of diagnostic agents such as contrast media, and therapeutic agents such as occlusion coils, into the peripheral and neuro vasculature.
1
2/2
DEVICE DESCRIPTION
The Micrus® Ascent™ Occlusion Balloon Catheter is a coaxial dual lumen balloon catheter comprised of an inner guidewire lumen and a separate outer lumen to inflate and deflate the balloon. The balloon catheter is designed for use over any .014" or smaller guidewire. The balloon can be inflated and deflated independently of guidewire position. The balloon is equipped with a vent hole for easy preparation and removal of air from the balloon, and with two radiopaque markers for balloon positioning.
SUBSTANTIAL EQUIVALENCE
The Micrus Ascent Occlusion Balloon Catheter is substantially equivalent to the MTI Hyperform Occlusion Balloon Catheter, the Cordis Commodore Occlusion Catheter, and the Target Sentry Occlusion Balloon Catheter in terms of intended use, design, specifications, and materials. These systems are all intended for use to assist in the temporary occlusion of peripheral vessels. The Micrus Ascent Occlusion Balloon Catheter is substantially equivalent to the Micrus Courier Microcatheter in terms of intended use, specifications, and materials. The Micrus Ascent Occlusion Balloon Catheter uses the same methods and materials in construction, packaging, and sterilization as its predicates. The modification to the device has not altered the fundamental technology of the predicate devices.
CONCLUSION
As described in this 510(k) Summary, Micrus Endovascular Corporation considers the Micrus Ascent Occlusion Balloon Catheter to be substantially equivalent to the predicate devices.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with flowing lines, representing the department's mission. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" is arranged in a circular fashion around the symbol. The logo is simple and monochromatic.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 2 7 2008
Micrus Endovascular Corporation % Mr. Patrick Lee Regulatory Affairs Specialist 821 Fox Lane San Jose, California 95131
Re: K080861
Trade/Device Name: The Micrus Ascent Occlusion Balloon Catheter Regulation Number: 21 CFR 870.4450 Regulation Name: Vascular clamp. Regulatory Class: II Product Code: MJN Dated: August 25, 2008 Received: August 26, 2008
Dear Mr. Patrick Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Mr. Patrick Lee
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark N. Milliman
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Micrus Ascent Occlusion Balloon Catheter 510(k) Premarket Notification
080861
Indications for Use 4.0
510(k) Number (if known): J
The Micrus Ascent Occlusion Balloon Catheter Device Name: _________________________________________________________________________________________________________________________________________________________________
Indications For Use:
The Micrus Ascent Occlusion Balloon Catheter is intended for use in the blood vessels of the peripheral and neuro vasculature where temporary occlusion is desired and offers a vessel selective technique of temporary vascular occlusion which is useful in selectively stopping or controlling blood flow. The Micrus Ascent Occlusion Balloon Catheter is also intended to assist in the delivery of diagnostic agents such as contrast media, and therapeutic agents such as occlusion coils, into the peripheral and neuro vasculature.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mark N. Malkuss
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
Page 1 of 1
510(k) Number
Micrus Endovascular Corporation